UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiac and cardiovascular systems (5) 5
kardiologi (5) 5
drug therapy, combination (4) 4
humans (4) 4
anti platelet therapy (3) 3
anticoagulants - adverse effects (3) 3
anticoagulants - therapeutic use (3) 3
arrhythmia/all (3) 3
atrial fibrillation - drug therapy (3) 3
cardiac (3) 3
catheterization/diagnostic interventional (3) 3
clinical medicine (3) 3
clinical trials (3) 3
dabigatran - adverse effects (3) 3
dabigatran - therapeutic use (3) 3
general clinical cardiology (3) 3
hemorrhage - chemically induced (3) 3
klinisk medicin (3) 3
life sciences & biomedicine (3) 3
management (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
pharmacology (3) 3
platelet aggregation inhibitors - therapeutic use (3) 3
purinergic p2y receptor antagonists - adverse effects (3) 3
purinergic p2y receptor antagonists - therapeutic use (3) 3
science & technology (3) 3
stroke prevention (3) 3
thrombosis/hypercoagulable states (3) 3
treatment outcome (3) 3
warfarin - adverse effects (3) 3
warfarin - therapeutic use (3) 3
anticoagulants (2) 2
antithrombins - adverse effects (2) 2
antithrombins - therapeutic use (2) 2
aspirin (2) 2
atrial fibrillation (2) 2
atrial fibrillation - complications (2) 2
atrial fibrillation - diagnosis (2) 2
atrial fibrillation - mortality (2) 2
cardiac arrhythmia (2) 2
cardiology (2) 2
clinical protocols (2) 2
coronary artery disease - complications (2) 2
coronary artery disease - diagnosis (2) 2
coronary artery disease - mortality (2) 2
coronary artery disease - therapy (2) 2
coronary thrombosis - etiology (2) 2
coronary thrombosis - prevention & control (2) 2
female (2) 2
male (2) 2
middle aged (2) 2
myocardial infarction - etiology (2) 2
myocardial infarction - prevention & control (2) 2
percutaneous coronary intervention - adverse effects (2) 2
percutaneous coronary intervention - instrumentation (2) 2
percutaneous coronary intervention - mortality (2) 2
platelet aggregation inhibitors - adverse effects (2) 2
prospective studies (2) 2
research design (2) 2
risk factors (2) 2
stents (2) 2
stroke (2) 2
stroke - etiology (2) 2
stroke - prevention & control (2) 2
thrombosis (2) 2
time factors (2) 2
trial designs (2) 2
warfarin (2) 2
1102 cardiovascular medicine and haematology (1) 1
abridged index medicus (1) 1
adenosine (1) 1
adenosine - adverse effects (1) 1
adenosine - analogs & derivatives (1) 1
adenosine - therapeutic use (1) 1
aged (1) 1
all (1) 1
angioplasty (1) 1
arrhythmia (1) 1
aspirin - therapeutic use (1) 1
atrial fibrillation - therapy (1) 1
benzhydryl compounds - adverse effects (1) 1
benzhydryl compounds - therapeutic use (1) 1
bleeding (1) 1
blood clot (1) 1
cardiac & cardiovascular systems (1) 1
cardiac patients (1) 1
cardiovascular diseases (1) 1
cardiovascular system & cardiology (1) 1
cardiovascular system & hematology (1) 1
care and treatment (1) 1
catheterization (1) 1
cerebral infarction (1) 1
clopidogrel (1) 1
continuing medical education (1) 1
dabigatran (1) 1
diabetes mellitus, type 2 - complications (1) 1
diabetes mellitus, type 2 - drug therapy (1) 1
diagnostic interventional (1) 1
dosage and administration (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 10/2017, Volume 377, Issue 16, pp. 1513 - 1524
In this trial, dabigatran plus a P2Y 12 inhibitor was compared with warfarin plus a P2Y 12 inhibitor and aspirin after PCI in patients with atrial... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Dabigatran - adverse effects | Ticlopidine - therapeutic use | Humans | Middle Aged | Warfarin - adverse effects | Male | Risk | Dabigatran - therapeutic use | Incidence | Warfarin - therapeutic use | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Therapy, Combination - adverse effects | Adenosine - adverse effects | Adenosine - therapeutic use | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Ticagrelor | Purinergic P2Y Receptor Antagonists - therapeutic use | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Atrial Fibrillation - therapy | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Ticlopidine - analogs & derivatives | Adenosine - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Percutaneous Coronary Intervention | Warfarin | Atrial fibrillation | Dosage and administration | Research | Thromboembolism | Hemorrhage | Health aspects | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Embolisms | Preventive medicine | Thrombosis | Bleeding | Embolism | Fibrillation | Cardiology | Drug therapy | Drug dosages | Geriatrics | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Clinical cardiology (Mahwah, N.J.), 10/2016, Volume 39, Issue 10, p. 555
Journal Article
2017, Volume 377, Issue 16
BACKGROUND: Triple antithrombotic therapy with warfarin plus two antiplatelet agents is the standard of care after percutaneous coronary intervention (PCI) for... 
Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin
Publication
2017, Volume 377, Issue 16
BACKGROUND Triple antithrombotic therapy with warfarin plus two antiplatelet agents is the standard of care after percutaneous coronary intervention (PCI) for... 
Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin
Publication
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.